Finance

Lists
SDPC:IDX
Millennium Pharmacon Internationl Tbk PT
202,00 IDR
-0,98%
(-2,00) 1D
23 ოქტ, 15:31:59 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SDPC...
Open
204 IDR
High
214 IDR
Low
199 IDR
Mkt. cap
257,35 მლრ.
Avg. vol.
716,32 ათ.
Volume
242,50 ათ.
Dividend
1,49%
Quarterly dividend
1 IDR
Ex-dividend date
8 ივნ. 2026
P/E ratio
6,23
52-wk high
228 IDR
52-wk low
135 IDR
EPS
32 IDR
Shares outstanding
1,27 მლრდ.
No. of employees
1 ათ.
Open
204 IDR
High
214 IDR
Low
199 IDR
Mkt. cap
257,35 მლრ.
Avg. vol.
716,32 ათ.
Volume
242,50 ათ.
Dividend
1,49%
Quarterly dividend
1 IDR
Ex-dividend date
8 ივნ. 2026
P/E ratio
6,23
52-wk high
228 IDR
52-wk low
135 IDR
EPS
32 IDR
Shares outstanding
1,27 მლრდ.
No. of employees
1 ათ.
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
25 წუთის წინ
A Johnson & Johnson banner is displayed on the front of the NYSE in New York
Chicago Tribune
Chicago Tribune
·
51 წუთის წინ
Today in History: Black Thursday
Reuters
Reuters
·
9 საათის წინ
Wall Street closes lower to end rocky week
About Millennium Pharmacon Internationl Tbk PT
CEO-
Employees1,2 ათ.
Founded1952
Headquarters-
SectorHealth care provider
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,06 ტრლ.
1,11 ტრლ.
1,02 ტრლ.
1,11 ტრლ.
Cost of goods sold
975,40 მლრ.
1,00 ტრლ.
930,34 მლრ.
1,02 ტრლ.
Cost of revenue
975,40 მლრ.
1,00 ტრლ.
930,34 მლრ.
1,02 ტრლ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,24 მლრდ.
61,14 მლრდ.
58,04 მლრდ.
62,13 მლრდ.
Operating expense
59,42 მლრდ.
71,31 მლრდ.
59,44 მლრდ.
62,19 მლრდ.
Total operating expenses
1,03 ტრლ.
1,07 ტრლ.
989,78 მლრ.
1,08 ტრლ.
Operating income
24,66 მლრდ.
33,66 მლრდ.
28,19 მლრდ.
32,27 მლრდ.
Other non operating income
-
-
-
-
EBT including unusual items
7,31 მლრდ.
21,04 მლრდ.
13,11 მლრდ.
15,00 მლრდ.
EBT excluding unusual items
7,31 მლრდ.
21,04 მლრდ.
13,11 მლრდ.
15,00 მლრდ.
Income tax expense
3,67 მლრდ.
2,95 მლრდ.
3,00 მლრდ.
5,55 მლრდ.
Effective tax rate
50,18%
14,05%
22,91%
36,97%
Other operating expenses
3,18 მლრდ.
10,17 მლრდ.
1,40 მლრდ.
61,09 მლნ.
Net income
3,64 მლრდ.
18,08 მლრდ.
10,10 მლრდ.
9,46 მლრდ.
Net profit margin
0,34%
1,63%
0,99%
0,85%
Earnings per share
-
-
-
-
Interest and investment income
41,47 მლნ.
45,33 მლნ.
37,63 მლნ.
59,17 მლნ.
Interest expense
-17,40 მლრდ.
-12,67 მლრდ.
-15,12 მლრდ.
-17,32 მლრდ.
Net interest expenses
-17,36 მლრდ.
-12,63 მლრდ.
-15,09 მლრდ.
-17,26 მლრდ.
Depreciation and amortization charges
-
-
-
-
EBITDA
27,16 მლრდ.
36,39 მლრდ.
29,93 მლრდ.
33,89 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები